Discover How LGC Use Serial-Passage Testing on Novel Combination Molecules

Find out how the Drug Development Services team at LGC measure the resistance development potential of new novel compounds against C. difficile-associated disease (CDAD). Ed Siegwart, Senior Scientist, in the Microbiology department at LGC discusses the benefits of serial-passage testing in drug resistance testing.